Major depressive disorder and medical illness: STAR*D outcomes Prakash MasandMeera Narasimhan Invited Commentary Pages: 165 - 166
The glycine site of NMDA receptors—A target for treatment of schizophrenia Joachim F. Hallmayer Clinical Trials Report Pages: 171 - 173
The relationship between delusions and hallucinations Brendan A. Maher OriginalPaper Pages: 179 - 183
Metacognitive control over false memories: A key determinant of delusional thinking Steffen MoritzTodd S. Woodward OriginalPaper Pages: 184 - 190
Metabolic syndrome in patients with schizophrenia: CATIE results Meera NarasimhanPrakash Masand Clinical Trials Report Pages: 213 - 214
Consultation-liaison psychiatry: How far have we come? Sherese AliCarrie ErnstGregory Fricchione OriginalPaper Pages: 215 - 222
Anxiety in medically III patients Rajnish MagoJohn-Paul GomezElisabeth J. S. Kunkel OriginalPaper Pages: 228 - 233
Treatment of depression in Parkinson’s disease Matthew MenzaRoseanne DeFronzo DobkinHumberto Marin OriginalPaper Pages: 234 - 240
Management of psychiatric comorbidity in fibromyalgia Lesley M. Arnold OriginalPaper Pages: 241 - 245
Psycho-oncology: Review and update Kathryn M. KashRajnish MagoElisabeth J. S. Kunkel OriginalPaper Pages: 246 - 252